Parkhurst NuVision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

SAN ANTONIO--()--Gregory D. Parkhurst, MD at Parkhurst NuVision in San Antonio, Texas, is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

“We have just begun enrolling patients in the IC-8 lens clinical study,” Dr. Parkhurst said. “Our team is looking forward to learning how small aperture technology may enhance a traditional monofocal IOL by providing a greater range of vision from near to far.”

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.

Dr. Parkhurst will be one of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

Parkhurst NuVision is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

  • At least 22 years of age.
  • Have cataracts in both eyes.
  • Are available, willing and able to participate in examinations and all follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Parkhurst NuVision at (844) 834-2020 or online at ParkhurstNuVision.com.

About Parkhurst NuVision

People who are looking to undergo vision correction surgery in the San Antonio, New Braunfels, Corpus Christi, and Uvalde areas, will find the region’s premier surgeon and facility at Parkhurst NuVision. Located conveniently within the San Antonio medical center, the physicians and staff at Parkhurst NuVision are eager to assist patients in achieving their best vision. To schedule your appointment at Parkhurst NuVision, please call (844)-834-2020 or visit the website at www.sanantonio-lasik.com.

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.

Contacts

Shelle Murach
Cunningham & Associates
714 206-4138
smurach@gmail.com

Release Summary

Parkhurst NuVision in San Antonio, Texas, is participating in the AcuFocus clinical study for the IC-8 intraocular lens designed for cataracts.

Contacts

Shelle Murach
Cunningham & Associates
714 206-4138
smurach@gmail.com